The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
William N. Pappano(AbbVie (United States)), Gary G. Chiang(Therapeutics Clinical Research)
Cited by 94
Related Papers
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|853
Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase
|Journal of Biological Chemistry|2005|557
Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold
|Bioorganic & Medicinal Chemistry|2004|136
Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells
|BMC Cancer|2014|28
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma
|Molecular Cancer Therapeutics|2024|6